EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In December 2024 — Where Do Tesla, Nvidia, Quantum Computing Stock Rank?
Brand Prescription Drugs to Rise an Average 4.5% in 2025
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
How Is The Market Feeling About Pfizer?
Leading And Lagging Sectors For January 1, 2025
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Eli Lilly Unusual Options Activity
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Last Trading Day of 2024
CompoSecure, Cemtrex And 3 Stocks To Watch Heading Into Tuesday
Takeda-backed Ascentage Pharma Files for $100M IPO
Sangamo Says Collaboration, License Agreement With Pfizer On Giroctocogene Fitelparvovec Will Terminate Effective April 21, 2025; Plans To Explore All Options To Commercialize The Asset, Including Seeking Potential New Partner
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
How Is The Market Feeling About Abbott Laboratories?
Weekly ETF Flows: Six Out of 11 Sectors Record Outflows; Bitcoin Sees First Outflow Since Trump's Victory in November
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Tech-Driven Gains Falter at Year-End
Leading And Lagging Sectors For December 30, 2024
Global enterprises are "fully powered" to borrow money! The scale will reach 8 trillion dollars in 2024, setting a record.
Bankers stated that low financing costs were the initial reason for companies to choose to issue Bonds early, as they wanted to avoid the market volatility risks that could arise around the USA elections. However, after Trump's election victory, the market's credit spreads further narrowed, prompting some companies to decide to lock in their borrowing needs for the following year in order to secure funds under favorable market conditions.